# Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas

> **NCT00555464** · PHASE2 · TERMINATED · sponsor: **Medical College of Wisconsin** · enrollment: 8 (actual)

## Conditions studied

- Hemangioma

## Interventions

- **DRUG:** Vincristine
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT00555464
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-11
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** The introduction of oral propranolol as a highly efficacious agent for infantile hemangiomas
- **Last updated:** 2013-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00555464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00555464, "Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00555464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*